We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -1.35% | 44.00 | 43.50 | 44.50 | 45.50 | 43.25 | 44.75 | 3,128,090 | 13:11:54 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.18 | 124.79M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/10/2021 12:55 | Grosstonnage True, but an acknowledgment that sales are being made of a Maiden product that has suffered from delays, would show some gearing towards valuing shareholders. It was also act as a remedy towards avatars on BB's telling lies and spooking potential investors | deme1 | |
21/10/2021 12:53 | I don't know of other businesses which give regular updates in numbers of sales of one of their product range. | grosstonnage | |
21/10/2021 12:43 | They can sell in the UK. As far as approved lists that remains to be seen. | tickboo | |
21/10/2021 12:40 | It does seem a poor outcome if they can't sell the LFT in the UK or get onto approved lists. They need to start delivering some value | money4me | |
21/10/2021 12:37 | I can confirm the positive feedback was from McNumbskull. | pwhite73 | |
21/10/2021 12:31 | Shame they have not given numbers Losta. positive feedback could be from one customer buying one lot. No doubt we are selling a good quantity but the market has to guess | deme1 | |
21/10/2021 12:29 | Part of the email sent by Avacta diagnostics this morning. Content deleted as imo I was sent it in error. | lostabillion | |
21/10/2021 12:17 | Not for me D1, too much going on at Avacta for that malarkey. Good luck if you are attempting it though. | lostabillion | |
21/10/2021 12:09 | Traders dream at the moe. Buy at £1.05 (ish) sell at £1.22 - £1.27 | deme1 | |
21/10/2021 12:02 | May I suggest you move on Parasite73 and take your axe with you. I’ve done enough research here to see right through your agenda! Keep that short open purely for our entertainment please! No more conversing with you, sorry. | lostabillion | |
21/10/2021 11:57 | Don't expect a reply, they only ask questions, do not answer any, all part of the training, roll on Monday, not expecting any news then but at least they MIGHT shut up | indyanna | |
21/10/2021 11:53 | Lostabillion - No update about AVA6000 will result in any sustained rise in the share price. AVA6000 is still at Phase I. There is no commercial value at this stage. Matters only become serious for oncology drugs at Phase II/III. AVCT are working on a cure for cancer. Cancer cells can easily be killed by many methods including drinking a bottle of weed killer. The problem with all cancer treatments is that they destroy healthy cells even when successful. If AVA6000 can allow drugs like doxorubicin to destroy cancer cells whilst protecting healthy cells then that is the cure for cancer. That is the cure that has eluded the world's major pharmaceutical companies for decades and has cost them trillions. What you need to look out for are papers published in medical journals by AVCT about the progress they are making on AVA6000. If all you're getting is RNS statements written by the nomad then forget it. That is the main difference between pharma companies that are genuinely working on cancer therapies and those that are not. They publish the progress of their work in medical journals to be reviewed by their peers all over the world. Indeed that is a requirement by the FDA that your research work is published so global pharmas, hospitals, scientists can challenge your findings. | pwhite73 | |
21/10/2021 11:51 | I was referring to Parasite73’s post! I suggest you register D1 ;-) | lostabillion | |
21/10/2021 11:41 | an update around the end of December on AVA6000 was already known. What have they sent out in their mailing list | deme1 | |
21/10/2021 11:38 | AVA6000 update around end of Dec. I think most here can wait 9 weeks or so for a potential multi multi rise on positive news on that front! | lostabillion | |
21/10/2021 11:31 | Losta Unless they are mentioning HUA approved then i don't care ;) | deme1 | |
21/10/2021 11:27 | deme1 - Tomorrow is D - Day for Avacta whatever happens tomorrow will be the last of the regular comments from me. My work is finished here. I'm not going to say I'll never comment again because I still have you all in my hearts. In the event of an emergency and what I mean by that is an RNS that attempts to convince you of progress when there is none I MAY comment. What is required here is approval for your LFT. AVA6000 is too far away to be of any concern for current shareholders. | pwhite73 | |
21/10/2021 11:25 | Goodbye Parasite73. | lostabillion | |
21/10/2021 11:19 | Anyone else on Avacta diagnostics news email alert list? :—))) | lostabillion | |
21/10/2021 11:17 | Pwhite What happened to "my last post" the other day? Seems you have continued to bombard the BB. Serious question | deme1 | |
21/10/2021 11:14 | BlimeyThe troll must be on overtime rate at 47p per post today. | grosstonnage | |
21/10/2021 11:09 | tickboo - "We have been shipping" Shipping to where? What countries or businesses do you know that are using the AVCT LFT. That's a serious question. | pwhite73 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions